Literature DB >> 19369403

Outcomes associated with race in males with nondialysis-dependent chronic kidney disease.

Csaba P Kovesdy1, John E Anderson, Stephen F Derose, Kamyar Kalantar-Zadeh.   

Abstract

BACKGROUND AND OBJECTIVES: Blacks are over-represented among dialysis patients, but they have better survival rates than whites. It is unclear if the over-representation of blacks on dialysis is due to faster loss of kidney function or greater survival (or both) in predialysis stages of chronic kidney disease (CKD). DESIGN, SETTING, PARTICIPANTS & MEASUREMENTS: We compared predialysis mortality, incidence of end stage renal disease (ESRD), and slopes of estimated GFR (eGFR) in 298 black versus 945 white male patients with moderate and advanced nondialysis-dependent CKD (NDD-CKD) from a single medical center. Mortality and ESRD incidence were compared in parametric survival models, and slopes of eGFR were assessed in mixed-effects models.
RESULTS: Blacks had lower crude mortality and higher crude ESRD incidence. The lower mortality in blacks was explained by differences in case mix, especially a lower prevalence of cardiovascular disease, and the higher incidence of ESRD was explained by differences in case mix and baseline kidney function. The slopes of eGFR were similar in blacks and whites.
CONCLUSIONS: Lower mortality in black versus white patients is also observed in NDD-CKD and can be accounted for by differences in clinical characteristics. Higher mortality of black patients in earlier stages of CKD may result in the selection of a subgroup with fewer comorbidities and better survival in later stages of CKD. The higher crude ESRD rate in blacks appears to result from lower mortality in late stages of CKD, not faster progression of CKD.

Entities:  

Mesh:

Year:  2009        PMID: 19369403      PMCID: PMC2676182          DOI: 10.2215/CJN.06031108

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  35 in total

Review 1.  Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency.

Authors:  Chi-Yuan Hsu; Glenn M Chertow; Gary C Curhan
Journal:  Kidney Int       Date:  2002-05       Impact factor: 10.612

2.  Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors.

Authors:  Michelle E Tarver-Carr; Neil R Powe; Mark S Eberhardt; Thomas A LaVeist; Raynard S Kington; Josef Coresh; Frederick L Brancati
Journal:  J Am Soc Nephrol       Date:  2002-09       Impact factor: 10.121

3.  Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects.

Authors:  Patrick Royston; Mahesh K B Parmar
Journal:  Stat Med       Date:  2002-08-15       Impact factor: 2.373

4.  Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies.

Authors:  Daniel E Weiner; Hocine Tighiouart; Manish G Amin; Paul C Stark; Bonnie MacLeod; John L Griffith; Deeb N Salem; Andrew S Levey; Mark J Sarnak
Journal:  J Am Soc Nephrol       Date:  2004-05       Impact factor: 10.121

5.  Racial differences in mortality among those with CKD.

Authors:  Rajnish Mehrotra; Dulcie Kermah; Linda Fried; Sharon Adler; Keith Norris
Journal:  J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 10.121

6.  Racial factors in the incidence and causation of end-stage renal disease (ESRD).

Authors:  R E Easterling
Journal:  Trans Am Soc Artif Intern Organs       Date:  1977

7.  Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate.

Authors:  J Lewis; L Agodoa; D Cheek; T Greene; J Middleton; D O'Connor; A Ojo; R Phillips; M Sika; J Wright
Journal:  Am J Kidney Dis       Date:  2001-10       Impact factor: 8.860

8.  Black-white inequalities in mortality and life expectancy, 1933-1999: implications for healthy people 2010.

Authors:  R S Levine; J E Foster; R E Fullilove; M T Fullilove; N C Briggs; P C Hull; B A Husaini; C H Hennekens
Journal:  Public Health Rep       Date:  2001 Sep-Oct       Impact factor: 2.792

9.  Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States.

Authors:  Chi-Yuan Hsu; Feng Lin; Eric Vittinghoff; Michael G Shlipak
Journal:  J Am Soc Nephrol       Date:  2003-11       Impact factor: 10.121

10.  Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization.

Authors:  Douglas S Keith; Gregory A Nichols; Christina M Gullion; Jonathan Betz Brown; David H Smith
Journal:  Arch Intern Med       Date:  2004-03-22
View more
  27 in total

1.  Racial and ethnic differences in mortality of hemodialysis patients: role of dietary and nutritional status and inflammation.

Authors:  Nazanin Noori; Csaba P Kovesdy; Ramanath Dukkipati; Usama Feroze; Miklos Z Molnar; Rachelle Bross; Allen R Nissenson; Joel D Kopple; Keith C Norris; Kamyar Kalantar-Zadeh
Journal:  Am J Nephrol       Date:  2011-02-04       Impact factor: 3.754

2.  Racial/Ethnic Differences in Left Ventricular Structure and Function in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort.

Authors:  Faraz S Ahmad; Xuan Cai; Katherine Kunkel; Ana C Ricardo; James P Lash; Dominic S Raj; Jiang He; Amanda H Anderson; Matthew J Budoff; Julie A Wright Nunes; Jason Roy; Jackson T Wright; Alan S Go; Martin G St John Sutton; John W Kusek; Tamara Isakova; Myles Wolf; Martin G Keane
Journal:  Am J Hypertens       Date:  2017-08-01       Impact factor: 2.689

3.  Racial disparities in kidney disease outcomes.

Authors:  Susanne B Nicholas; Kamyar Kalantar-Zadeh; Keith C Norris
Journal:  Semin Nephrol       Date:  2013-09       Impact factor: 5.299

Review 4.  Modeling longitudinal data and its impact on survival in observational nephrology studies: tools and considerations.

Authors:  Elani Streja; Leanne Goldstein; Melissa Soohoo; Yoshitsugu Obi; Kamyar Kalantar-Zadeh; Connie M Rhee
Journal:  Nephrol Dial Transplant       Date:  2017-04-01       Impact factor: 5.992

Review 5.  Social Determinants of Racial Disparities in CKD.

Authors:  Jenna M Norton; Marva M Moxey-Mims; Paul W Eggers; Andrew S Narva; Robert A Star; Paul L Kimmel; Griffin P Rodgers
Journal:  J Am Soc Nephrol       Date:  2016-05-13       Impact factor: 10.121

6.  Roma ethnicity and clinical outcomes in kidney transplant recipients.

Authors:  Miklos Z Molnar; Robert M Langer; Adam Remport; Maria E Czira; Katalin Rajczy; Kamyar Kalantar-Zadeh; Csaba P Kovesdy; Marta Novak; Istvan Mucsi; Laszlo Rosivall
Journal:  Int Urol Nephrol       Date:  2011-11-25       Impact factor: 2.370

7.  Racial differences in estimated GFR decline, ESRD, and mortality in an integrated health system.

Authors:  Stephen F Derose; Mark P Rutkowski; Peter W Crooks; Jiaxiao M Shi; Jean Q Wang; Kamyar Kalantar-Zadeh; Csaba P Kovesdy; Nathan W Levin; Steven J Jacobsen
Journal:  Am J Kidney Dis       Date:  2013-03-15       Impact factor: 8.860

Review 8.  Essential hypertension and risk of nephropathy: a reappraisal.

Authors:  Mariana Murea; Barry I Freedman
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-05       Impact factor: 2.894

9.  Race/Ethnicity and Cardiovascular Outcomes in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC Studies.

Authors:  James P Lash; Ana C Ricardo; Jason Roy; Rajat Deo; Michael Fischer; John Flack; Jiang He; Martin Keane; Claudia Lora; Akinlolu Ojo; Mahboob Rahman; Susan Steigerwalt; Kaixiang Tao; Myles Wolf; Jackson T Wright; Alan S Go
Journal:  Am J Kidney Dis       Date:  2016-05-19       Impact factor: 8.860

10.  Ethnic differences in the relationship between albuminuria and calcified atherosclerotic plaque: the African American-diabetes heart study.

Authors:  Jasmin Divers; Lynne E Wagenknecht; Donald W Bowden; J Jeffrey Carr; R Caresse Hightower; Jianzhao Xu; Carl D Langefeld; Barry I Freedman
Journal:  Diabetes Care       Date:  2009-10-13       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.